The BDNF-TrkB signaling pathway has been previously demonstrated to modulate brain inflammation and protect against hippocampus injury, suggesting that ADSC-mediated protective effects could be linked to reduced symptoms of depression [98,99]. The gene discussed is NTRK2; the disease is depressive symptom measurement.